GENE ONLINE|News &
Opinion
Blog

Insilico Medicine
Insilico Medicine Reports Breakthrough Phase IIa Results for AI-Driven IPF Drug ISM001-055
2024-11-19
Insilico Medicine Pinpoints New Targets for ALS With AI
2022-07-08
Insilico’s AI Pipeline for Drug Discovery To Grow with New Partnership
2020-11-11
Insilico Medicine, Taisho Partnership Sets Precedent in Drug Discovery and Development
2020-10-18
First AI-Designed Drug to Enter Phase I Clinical Trial
2020-02-05
Weekly in Asia | SEP-1
2019-09-17
LATEST
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-16
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top